Business Trends

Jun 15, 2016
BioPharm International
New drug approval policies promote industry growth and injectable contract manufacturing opportunities in China.
Jun 15, 2016
BioPharm International
By BioPharm International Editors
Contract service providers debate the pros and cons of consolidation, accelerated drug approvals, regulatory issues, and the impact of new therapies.
Jun 01, 2016
By BioPharm International Editors
Insight on the new regulatory framework from the China Food and Drug Administration
May 31, 2016
BioPharm sat down with an intellectual property lawyer to examine how companies are protected when they engage in activities where sharing of trade secrets must occur.
May 01, 2016
BioPharm International
Policies for patient access to life-saving therapies must keep pace with biomedical innovation.
Apr 29, 2016
BioPharm International
Immuno-oncology drugs are demonstrating patient benefits, but growing resistance to the high cost has implications for patients, market access, and manufacturers.
Mar 01, 2016
BioPharm International
Thought leaders tackle drug shortages and biomanufacturing challenges.
Feb 01, 2016
BioPharm International
Report: Biologics contribute to rebirth of biopharma innovation.
Jan 01, 2016
BioPharm International
Corporate restructurings, regulatory initiatives, and biosimilars will shape biopharma development in 2016.
Jan 01, 2016
BioPharm International
Infrastructure and payer decisions will determine drug choices in emerging and developed regions.
native1_300x100
lorem ipsum